drugset / Trial / NCT00134394
Etanercept With Tacrolimus for Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
The study is designed to evaluate the efficacy of etanercept 50 mg subcutaneously (SQ) weekly plus tacrolimus 0.1% topical ointment twice daily compared to etanercept 50 mg SQ weekly plus placebo ointment twice daily.
Timeline
- Start
- 2005-02
- Primary completion
- —
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tacrolimus | Small molecule | 0.1 % | Topical |
| Background | Etanercept | Protein / enzyme biologic | 50 mg | Subcutaneous |